Skip to main content
S 3161 116th Congress Senate Health Administrative law and regulatory procedures Aging Appropriations Budget deficits and national debt Cancer Child health Computers and information technology Department of Health and Human Services Drug safety, medical device, and laboratory regulation Drug therapy Education programs funding Environmental health Executive agency funding and structure Food and Drug Administration (FDA) Genetics Government trust funds Health care costs and insurance Health information and medical records Health personnel

National Biomedical Research Act

Introduced: January 8, 2020 Introduced by: Warren, Elizabeth Democratic · Massachusetts See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 8, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jan 8, 2020
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

National Biomedical Research Act

This bill establishes and makes deposits through FY2029 into the Biomedical Innovation Fund for initiatives at the National Institutes of Health and the Food and Drug Administration for advancing medical innovation, including by supporting (1) research for disease prevention, diagnosis, and treatment; (2) research for diseases that disproportionally account for federal health care spending; (3) the development, review, and post-market surveillance of medical products; and (4) other innovative research.

What's happening now January 8, 2020

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 9
All 9 Democratic 8 Independent 1
D
Baldwin, Tammy
Wisconsin · Jan 8, 2020
 D
Booker, Cory A.
New Jersey · Jan 8, 2020
 D
Hirono, Mazie K.
Hawaii · Jan 8, 2020
 D
Kaine, Tim
Virginia · Jan 8, 2020
 D
Markey, Edward J.
Massachusetts · Jan 8, 2020
 D
Murphy, Christopher
Connecticut · Jan 8, 2020
 I
Sanders, Bernard
Vermont · Jan 8, 2020
 D
Van Hollen, Chris
Maryland · Jan 8, 2020
 D
Whitehouse, Sheldon
Rhode Island · Jan 8, 2020
Cite this page click to expand
APA
U.S. Congress. (2026). S. 3161: National Biomedical Research Act. 116th Congress. Open America. https://openamerica.io/bill/116-S-3161/
MLA
"S. 3161: National Biomedical Research Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-3161/.
Bluebook (legal)
S. 3161, 116th Cong. (2026), https://openamerica.io/bill/116-S-3161/.
Markdown link
[S. 3161: National Biomedical Research Act](https://openamerica.io/bill/116-S-3161/)
Report a problem